Get started
Treace Medical Concepts, Inc.Treace Medical Concepts, Inc.Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

TMCI chart


Full chart

TMCI upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪433.59 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.99 USD
Net income (FY)
‪−49.53 M‬ USD
Revenue (FY)
‪187.12 M‬ USD
Shares float
‪45.56 M‬
Beta (1Y)
3.16

Employees


Employees (FY)
516
Change (1Y)
+93 +21.99%
Revenue / Employee (1Y)
‪362.63 K‬ USD
Net income / Employee (1Y)
‪−95.98 K‬ USD

About Treace Medical Concepts, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
John T. Treace
Website
treace.com
Headquarters
Ponte Vedra Beach
Founded
2013
FIGI
BBG00GQKR6M4
Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

TMCI news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of TMCI is 6.97 USD — it has increased by 0.14% in the past 24 hours. Watch Treace Medical Concepts, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Treace Medical Concepts, Inc. stocks are traded under the ticker TMCI.
TMCI stock has fallen by −7.44% compared to the previous week, the month change is a −12.55% fall, over the last year Treace Medical Concepts, Inc. has showed a −44.02% decrease.
We've gathered analysts' opinions on Treace Medical Concepts, Inc. future price: according to them, TMCI price has a max estimate of 8.40 USD and a min estimate of 7.50 USD. Watch TMCI chart and read a more detailed Treace Medical Concepts, Inc. stock forecast: see what analysts think of Treace Medical Concepts, Inc. and suggest that you do with its stocks.
TMCI reached its all-time high on Jun 14, 2021 with the price of 37.17 USD, and its all-time low was 3.92 USD and was reached on May 8, 2024. View more price dynamics on TMCI chart.
See other stocks reaching their highest and lowest prices.
TMCI stock is 3.25% volatile and has beta coefficient of 3.16. Track Treace Medical Concepts, Inc. stock price on the chart and check out the list of the most volatile stocks — is Treace Medical Concepts, Inc. there?
Today Treace Medical Concepts, Inc. has the market capitalization of ‪433.59 M‬, it has decreased by −4.79% over the last week.
Yes, you can track Treace Medical Concepts, Inc. financials in yearly and quarterly reports right on TradingView.
Treace Medical Concepts, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
TMCI earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.27 USD resulting in a 7.98% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about Treace Medical Concepts, Inc. earnings.
Treace Medical Concepts, Inc. revenue for the last quarter amounts to ‪45.09 M‬ USD, despite the estimated figure of ‪43.48 M‬ USD. In the next quarter, revenue is expected to reach ‪67.02 M‬ USD.
TMCI net income for the last quarter is ‪−15.36 M‬ USD, while the quarter before that showed ‪−21.21 M‬ USD of net income which accounts for 27.57% change. Track more Treace Medical Concepts, Inc. financial stats to get the full picture.
No, TMCI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 516.00 employees. See our rating of the largest employees — is Treace Medical Concepts, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Treace Medical Concepts, Inc. EBITDA is ‪−54.31 M‬ USD, and current EBITDA margin is −24.62%. See more stats in Treace Medical Concepts, Inc. financial statements.
Like other stocks, TMCI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Treace Medical Concepts, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Treace Medical Concepts, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Treace Medical Concepts, Inc. stock shows the sell signal. See more of Treace Medical Concepts, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.